| pubmed-article:3549902 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3549902 | lifeskim:mentions | umls-concept:C0005961 | lld:lifeskim |
| pubmed-article:3549902 | lifeskim:mentions | umls-concept:C0004561 | lld:lifeskim |
| pubmed-article:3549902 | lifeskim:mentions | umls-concept:C0815089 | lld:lifeskim |
| pubmed-article:3549902 | lifeskim:mentions | umls-concept:C0851285 | lld:lifeskim |
| pubmed-article:3549902 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:3549902 | pubmed:dateCreated | 1987-5-6 | lld:pubmed |
| pubmed-article:3549902 | pubmed:abstractText | Antibody secreting B lymphocytes from immunized donors can be adoptively transferred after T cell-depleted marrow transplantation to produce protective levels of antibody in the recipient. We have investigated whether these transferred lymphocytes remain subject to continued clonal selection and subsequently became memory B cells even in the initial absence of T cells. Twenty-eight donor/recipient pairs were randomized pretransplant to be immunized or not with tetanus toxoid (TT). The recipients were then vaccinated with TT at 3, 6, and 12 mo posttransplant, and the anti-TT antibody response (IgG and IgM) was measured. Only when both donor and recipient were immunized pretransplant could the recipient respond to antigen challenge within the first year posttransplant. Examination of the spectrotype pattern of the recipient anti-TT antibody shows that selection of B cell clones continues, so that T cell depletion does not prevent the appearance of oligoclonal antibody responses. However, because the spectrotype pattern of the recipient did not match the donors, B cell regulatory mechanisms in donor and recipient are nonidentical. These data contrast with observations made in recipients of non-T cell-depleted marrow and serve to illustrate the role of T lymphocytes in the induction and regulation of secondary antibody responses in man. The results also suggest that optimal humoral responses to any antigen after T cell depletion can only occur when both donor and recipient are immunized pretransplant, a prediction borne out by studies on the influence of donor cytomegalovirus status on the severity of cytomegalovirus infection in the recipient. | lld:pubmed |
| pubmed-article:3549902 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3549902 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549902 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3549902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549902 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3549902 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:3549902 | pubmed:issn | 0022-1767 | lld:pubmed |
| pubmed-article:3549902 | pubmed:author | pubmed-author:HoffbrandA... | lld:pubmed |
| pubmed-article:3549902 | pubmed:author | pubmed-author:ThompsonE JEJ | lld:pubmed |
| pubmed-article:3549902 | pubmed:author | pubmed-author:PrenticeH GHG | lld:pubmed |
| pubmed-article:3549902 | pubmed:author | pubmed-author:BrennerM KMK | lld:pubmed |
| pubmed-article:3549902 | pubmed:author | pubmed-author:WimperisJ ZJZ | lld:pubmed |
| pubmed-article:3549902 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3549902 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:3549902 | pubmed:volume | 138 | lld:pubmed |
| pubmed-article:3549902 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3549902 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3549902 | pubmed:pagination | 2445-50 | lld:pubmed |
| pubmed-article:3549902 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:meshHeading | pubmed-meshheading:3549902-... | lld:pubmed |
| pubmed-article:3549902 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3549902 | pubmed:articleTitle | B cell development and regulation after T cell-depleted marrow transplantation. | lld:pubmed |
| pubmed-article:3549902 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3549902 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:3549902 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:3549902 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3549902 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3549902 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3549902 | lld:pubmed |
